Rep. Betty McCollum

Maddy summaryHR 2584, the SAVE Act, creates a new federal criminal offense for assaulting or intimidating hospital employees while they're performing their duties, punishable by up to 10 years in prison, with enhanced penalties for using weapons, causing injury, or during public emergencies. The bill authorizes $25 million annually in federal grants to hospitals for violence prevention programs, including staff training, security technologies like panic buttons and video surveillance, and coordination with law enforcement. It defines "hospital" broadly to include various medical facilities such as long-term care hospitals, rehabilitation facilities, and critical access hospitals. The legislation directly affects hospital workers and medical facilities by establishing federal criminal penalties for violence against employees and providing funding to improve workplace safety. The law aims to address the rising problem of workplace violence against healthcare workers, which the bill states has increased since 2011.

Maddy summaryThe Family Violence Prevention and Services Improvement Act of 2023 amends the Family Violence Prevention and Services Act to improve services for victims of domestic violence, dating violence, and family violence. The bill authorizes $270 million annually for fiscal years 2024-2028, with specific allocations including 12.5% for Tribal grantees, 2.5% for culturally specific services, and funds for national hotlines and resource centers. It establishes a national domestic violence hotline, a National Indian Domestic Violence Hotline, and resource centers for Alaska Native and Native Hawaiian populations, requiring all services to be trauma-informed, culturally relevant, and accessible to underserved populations including racial and ethnic minorities, people with disabilities, and Tribal communities. The bill also mandates a study on financial stability support for survivors of domestic violence.

Maddy summaryHR 2630, the Safe Step Act, requires group health plans and health insurance issuers to establish a clear, transparent process for patients or their doctors to request exceptions to medication step therapy protocols. These protocols typically force patients to try cheaper drugs first before covering more expensive alternatives. The bill mandates that plans must approve exceptions when prior treatments failed, delay would cause serious harm, a treatment is unsafe, or a patient is stable on a previously approved drug, with strict 72-hour (or 24-hour in emergencies) decision timelines. It also requires plans to publish the exception process online and limit documentation requests to only necessary medical information. This law directly affects health insurers, employers offering health plans, and patients using step therapy for prescription drugs.

Maddy summaryHJRES 54 proposes a constitutional amendment stating that only natural persons (human beings) have rights protected by the U.S. Constitution, explicitly denying constitutional rights to corporations, limited liability companies, and other artificial entities. It would require governments to regulate or restrict corporate political contributions and spending to ensure equal access to elections, mandate public disclosure of all political spending, and clarify that campaign finance rules do not violate the First Amendment. This amendment directly affects corporations and other artificial entities by removing their constitutional standing in legal challenges and subjecting their political activities to stricter government oversight. If passed, it would fundamentally change how corporations interact with election laws and constitutional protections, though it preserves press freedom under Section 3. The bill is a proposed amendment requiring ratification by 3/4 of state legislatures to become part of the Constitution.

Securing Access to Lower Taxes by ensuring Deductibility Act or the SALT Deductibility Act This bill repeals the temporary restrictions in taxable years 2018 through 2025 on the deductibility of state and local taxes.

Maddy summaryHR 2402, the Alan Reinstein Ban Asbestos Now Act of 2023, bans the manufacture, processing, use, and sale of commercial asbestos (including specific types like chrysotile and crocidolite) in the U.S. starting one year after enactment, with key exceptions. It allows the chlor-alkali industry to continue using asbestos for diaphragm manufacturing until two years after enactment and permits limited national security exemptions for up to three years with public disclosure. The bill also requires the EPA and HHS to create public education resources about asbestos health risks and mitigation options. This directly affects manufacturers, distributors, and users of commercial asbestos products, excluding asbestos present only as an impurity.

Maddy summaryHR 2439, the Ally’s Act, requires most private health insurance plans to cover hearing-related services and devices for qualifying individuals. It mandates coverage for cochlear implants, bone conduction devices, maintenance, upgrades every five years, hearing assessments, surgery, and rehabilitation, without separate cost-sharing or medical necessity reviews. This directly affects people with hearing loss who need implantable devices, as defined by a physician or audiologist. The law applies to group health plans under the Public Health Service Act, ERISA, and Internal Revenue Code, taking effect for plan years beginning January 1, 2025.

Resident Physician Shortage Reduction Act of 2023 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. Current law provides for an increase of up to 200 positions per fiscal year beginning in FY2023, with a total increase of 1,000 positions; each hospital may receive up to 25 additional positions. Current law also provides for an additional increase of up to 200 positions for FY2026, with at least 100 of these positions for psychiatry or related specialties; each hospital may receive up to 10 additional positions. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2025-FY2031; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.

Maddy summaryHR 1839, the Combating Illicit Xylazine Act, makes the illicit use and distribution of xylazine a federal crime by adding it to the Controlled Substances Act. The bill broadly defines xylazine to cover numerous chemical variants and prohibits human use or non-licit distribution, while preserving legitimate veterinary and pharmaceutical uses. It requires tracking xylazine in drug supply chains and mandates two reports to Congress within 1 and 4 years on its prevalence, sources, and whether it should be rescheduled. The bill directly affects individuals distributing or using xylazine illicitly, including as an additive to drugs like fentanyl, and aims to address its public health risks. Congress declared illicit xylazine an "emerging drug threat" under existing law.

Maddy summaryHR 1826 (PSA Screening for HIM Act) requires health insurance plans and issuers to cover prostate cancer screenings without out-of-pocket costs for men aged 40 and over who are at high risk of prostate cancer. This directly affects African-American men and men with a family history of prostate cancer (defined as having a first-degree relative diagnosed with or who died from prostate cancer). The bill mandates coverage for evidence-based screenings under the same requirements as other preventive services, effective for plan years starting January 1, 2024. It aims to address disparities in prostate cancer outcomes by removing financial barriers to early detection for high-risk groups.